首页> 外文期刊>Journal of Pharmacological and Toxicological Methods >The anesthetized guinea pig: An effective early cardiovascular derisking and lead optimization model
【24h】

The anesthetized guinea pig: An effective early cardiovascular derisking and lead optimization model

机译:麻醉的豚鼠:有效的早期心血管除颤和铅优化模型

获取原文
获取原文并翻译 | 示例
       

摘要

Introduction: In recent years, the anesthetized guinea pig has been used increasingly to evaluate the cardiovascular effects of drug-candidate molecules during lead optimization prior to conducting longer, more resource intensive safety pharmacology and toxicology studies. The aim of these studies was to evaluate the correlations between pharmacologically-induced ECG changes in the anesthetized cardiovascular guinea pig (CVGP) with ECG changes in conscious non-rodent telemetry models, human clinical studies and effects on key cardiac ion channels. Methods: We compared the effects of 38 agents on ion channel inhibition to their ECG effects in the CVGP. 26 of these agents were also evaluated in non-rodent telemetry and compared to the results in the CVGP. Results: The CVGP was highly sensitive for detecting QTc, PR and QRS interval prolongation mediated by inhibition of hERG, hCav1.2 and hNav1.5, respectively. There were robust correlations between ion channel inhibitory potencies and the free plasma concentrations (Cu) producing prolongation of the QTc, PR or QRS interval. Further evaluation showed that ECG changes in the CVGP were predictive of their effects on the QTc, PR and QRS intervals in non-rodent telemetry models with 92%, 92% and 100% accuracy, respectively. The CVGP proved to be 100% specific and 88%, 75% and 100% sensitive for QTc, PR and QRS interval prolongation, respectively. Similarly, the Cu that prolonged the QTc, PR and QRS in CVGP and humans correlated well. Discussion: The CVGP is a sensitive model for assessing QTc, PR and QRS prolongation elicited by effects on hERG, hCav1.2 and hNav1.5, respectively. ECG changes in the CVGP are predictive of changes in non-rodent telemetry models and in humans (QTc). ECG parameters can be reliably evaluated with the CVGP model which increases the efficiency of CV derisking. Importantly, the design and implementation of this model is consistent with the "3Rs" for animal research.
机译:简介:近年来,在进行更长时间,更耗费资源的安全药理学和毒理学研究之前,麻醉的豚鼠已越来越多地用于铅优化过程中评估候选药物分子的心血管作用。这些研究的目的是评估在有意识的非啮齿动物遥测模型中,药理学诱导的心血管豚鼠(CVGP)的ECG变化与ECG变化,人类临床研究以及对关键心脏离子通道的影响之间的相关性。方法:我们将38种药物对离子通道抑制的作用与其在CVGP中的ECG作用进行了比较。还用非啮齿动物遥测技术评估了其中的26种药物,并将其与CVGP中的结果进行了比较。结果:CVGP对检测分别由抑制hERG,hCav1.2和hNav1.5介导的QTc,PR和QRS间隔延长非常敏感。离子通道抑制能力与产生QTc,PR或QRS间隔延长的游离血浆浓度(Cu)之间存在密切的相关性。进一步的评估表明,在非啮齿动物遥测模型中,CVGP中的ECG变化可预测其对QTc,PR和QRS间隔的影响,准确度分别为92%,92%和100%。 CVGP被证明对QTc,PR和QRS间隔延长分别具有100%特异性和88%,75%和100%敏感性。同样,延长CVGP与人的QTc,PR和QRS的铜的相关性也很好。讨论:CVGP是一种敏感模型,用于评估分别对hERG,hCav1.2和hNav1.5的作用引起的QTc,PR和QRS延长。 CVGP中的ECG变化可预测非啮齿动物遥测模型和人类(QTc)的变化。使用CVGP模型可以可靠地评估ECG参数,从而提高了CV除颤的效率。重要的是,此模型的设计和实现与动物研究的“ 3R”保持一致。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号